Med School Research Scientist Timsy Uppal and Engineering post-doctoral researcher Bhaskar Vadlamani testing the SARS-CoV-2 nanosensor.
University of Nevada, Reno engineers and virologists team up for novel approach
Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results in Mano Misra’s lab at the University of Nevada, Reno. The test uses a nanotube-based electrochemical biosensor, a similar technology that Misra has used in the past for detecting tuberculosis and colorectal cancer as well as detection of biomarkers for food safety.
Professor Misra, in the University’s College of Engineering Chemical and Materials Department, has been working on nano-sensors for 10 years. He has expertise in detecting a specific biomarker in tuberculosis patients’ breath using a metal functionalized nano sensor.
“I thought that similar technology can be used to detect the SARS-CoV-2 virus, which is a folded protein,” Misra said. “This is Point of Care testing to assess the exposure to COVID-19. We do not need a laboratory setting or trained health care workers to administer the test. Electrochemical biosensors are advantageous for sensing purposes as they are sensitive, accurate and simple.”
The test does not require a blood sample, it is run using a nasal swab or even exhaled breath, which has biomarkers of COVID-19. Misra and his team have successfully demonstrated a simple, inexpensive, rapid and non-invasive diagnostic platform that has the potential to effectively detect the SARS-CoV-2 virus.
The team includes Associate Professor Subhash Verma, virologist, and Research Scientist Timsy Uppal at the University’s School of Medicine, and Misra’s post-doctoral researcher Bhaskar Vadlamani.
“Our role on this project is to provide viral material to be used for detection by the nanomaterial sensor developed by Mano,” Verma said. “Mano contacted me back in April or May and asked whether we can collaborate to develop a test to detect SARS-CoV-2 infection by analyzing patients’ breath. That’s where we came in, to provide biological material and started with providing the surface protein of the virus, which can be used for detecting the presence of the virus.”
Verma, an expert on SARS-CoV-2, synthesized and prepared the antigenic protein of COVID-19 virus in his laboratory, SARS-CoV-2 receptor binding domain protein, for the preliminary testing and determining the sensitivity of our nano sensor. Synthesizing and purification of viral proteins is usual and routine work in a virology laboratory.
“Our lab is a virology laboratory, which works on different viruses, and we have been working on SARS-CoV-2 from the beginning of the outbreak,” he said. “Our genomics and diagnostic group have been sequencing the SARS-CoV-2 from the nasal swabs of COVID-19 patients of the state of Nevada to determine mutational changes in the virus while SARS-CoV-2 circulates in our population.”
The team developed co-metal functionalized nanotubes as a sensing material for electrochemical detection of the protein. They confirmed the biosensor’s potential for clinical application by directly analyzing the RBD of the Spike glycoprotein on the sensor.
The team plans to move to the next step of sensor validation on the actual COVID-19 patients swabs stored in the Viral Transport Medium (VTM) and have applied for funding to develop a specific and inexpensive point-of-care sensor for a rapid detection of COVID-19 virus in saliva or breath of infected individuals.
“A rapid and accurate testing method is critical to establishing a rigorous testing protocol to allow us to continue our operations while maximizing the safety of our students, faculty and staff,” College of Engineering Dean Manos Maragakis said. “I am excited and proud that a research team led by faculty from the College of Engineering in collaboration with faculty from our Medical School are leading such a promising and innovative effort. I am looking forward to the outcome.”
The developed approach also has the potential for diagnosis of other respiratory viral diseases by identifying appropriate metallic elements to functionalize nanotubes.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- U of L research team looks to combat Clubroot with rapid detection system
The University of Lethbridge International Genetically-Engineered Machine team -- or iGEM team -- is working to counteract a disease that affects canola crops.
- Impact of outbreaks of Covid-19 in Craigavon Hospital and Daisy Hill Hospital in Newry which led to 15 patients dying was 'catastrophic'
However, there was no screening of inpatients or healthcare workers at regular intervals. The absence of such screening hampered early detection of HA-COVID-19 (hospital acquired) and the ...
- Up to 200,000 to be enrolled in UK winter Covid-19 infection study
The study is a scaled-down version of the ‘gold standard’ Covid-19 infection study conducted in the UK during the pandemic.
- COVID-19 Linked to Fatal Brain Disease in US Man
COVID-19 has been associated with a fatal brain ailment responsible for the death of a 62-year-old man in the United States.
- Harbinger Health raises $140M Series B for cancer detection
Harbinger Health, a Cambridge, Massachusetts-based company focused on helping detect cancer early, raised $140 million in Series B funding. Why it matters: Certain cancers will likely rise ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”Covid-19 detection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
- What is Disease X? How scientists are preparing for the next pandemic
The term was coined years ago as a way of getting scientists to work on medical countermeasures for unknown infectious threats.
- U.S. Centers for Disease Control and Prevention Selects Verily to Support National Wastewater Monitoring
Multi-year collaboration utilizes Verily's Wastewater program to detect the spread of pathogens, including SARS-CoV-2 and MPXV Verily, an Alphabet precision health technology company, today announced ...
- The Molecular Microbiology of SARS-CoV-2: Detection Methods and Infection Mechanism
SARS-CoV-2 is a newly discovered human coronavirus group (HCoV), which are single-stranded RNA viruses belonging to the family of Coronaviridae. A range of respiratory diseases have been induced by ...
- qPCR for SARS-CoV-2 Detection and Research: Introduction, Principles, and Applications
The kit designs primers/probes for the identification of SARS-CoV-2 with specific ORF1a/b genes (labeled by FAM) and N genes (labeled by VIC). In relation, the kit also includes the human gene RNase P ...
- Successful optical biosensing using dual optical combs: High sensitivity and rapid detection of biomolecules
However, they have proven insufficient in terms of sensitivity for the ultra-early detection of novel coronavirus (SARS-CoV-2) and cancer cells. A research group comprising Prof. Takeshi Yasui and ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”SARS-CoV-2 detection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]